Testosterone therapy increased threefold in 10 years; One quarter took the therapy without being tested for testostereone levels

Prescriptions for testosterone therapy have increased significantly during the last 10 years, according to a study in the June issue of JAMA Internal Medicine conducted by researchers at the University of Texas Medical Branch.

About 50 percent of the men in the study who had received testosterone therapy had been diagnosed as having hypogonadism, a condition where a man is unable to produce the normal levels of testosterone. 

But the study also found that, among new users of a prescription androgen product, about 25 percent did not have their testosterone levels tested before starting the treatment.  In addition, it’s unclear what proportion of the 75 percent who were tested had a low level of testosterone.

Click here for the original UTMB news release

See video explaining main findings of the study